Aoxin Q & M Dental Group Limited (Catalist:1D4) entered into a conditional sale and purchase deed agreement to acquire 49% stake in Acumen Diagnostics Pte. Ltd from shareholders, Ong Siew Hwa and Acumen Holdings Pte. Ltd. for SGD 26.7 million on October 4, 2021. Upon completion of the acquisition, Aoxin Q & M will directly hold 49% of Acumen Diagnostics, with Q & M holding the balance of 51%. Q & M's total effective ownership of Acumen Diagnostics will thus amount to 67.15%, based on its 32.95% equity stake in Aoxin Q & M. Acquisition will be immediately profit accretive. Claudia Teo and Huang Zhihao of Harry Elias Partnership acted as legal advisors to Aoxin Q & M Dental Group Limited in the deal.

Aoxin Q & M Dental Group Limited (Catalist:1D4) completed the acquisition of 49% stake in Acumen Diagnostics Pte. Ltd from shareholders, Ong Siew Hwa and Acumen Holdings Pte. Ltd. on November 1, 2021.